Figure 4. Forest plots showing changes of serum pro-inflammatory cytokines of the eligible trials comparing low-molecular weight heparin to the usual treatment.
Interleukin-6 (A); tumor necrosis factor-α (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.